ResMed Inc. (RMD) - Breathe easy

November 5, 2024

ResMed Inc. develops, manufactures, distributes, and markets medical device and cloud-based software applications targeting the management of sleep apnoea. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service.

The company delivered a strong September quarter result, with 11% revenue growth translating to 35% earnings per share growth. Revenues were 3% ahead of consensus due to higher rates of flow generator growth.

The gross margin of 59.2% aligned with expectations, while operating expenses were slightly ahead of forecasts.

Net operating cash flow increased by 14% compared to the previous corresponding period, despite higher inventory due to rebalancing sea versus air freight. Net debt fell, while the value of share buyback program was boosted.

ResMed upped it FY25 EPS guidance thanks to jump higher flow generator revenues. Revenue growth for the current quarter is forecast at 10%. We forecast the company will be able to generate annualised EPS growth of 13% for the next few years, which justifies its current trading multiples. We ticked our price target up from $39.25 to $40.05 following the quarterly.

Insights that count

Discover the best opportunities to outperform the market. Our research team dig deep into the market, company and stock data to bring you insights others might overlook.

Mineral Resources (MIN) – Strong operational result

Mineral Resources offers mining services in Australia, Asia, and internationally, as well as having its own operations in iron ore and lithium.

Learn More

Ventia Services Group (VNT) – Promising outlook

Ventia Services Group provides infrastructure services in Australia and New Zealand and operates across a wide variety of sectors including Defence bases, telecommunications, water, and the renewable energy sector.

Learn More

Sigma Health (SIG) – London Calling

Sigma Healthcare operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia, with its flagship brands being Chemist Warehouse, Amcal, and Discount Drug stores.

Learn More

Want to keep up to
date on our latest news & insights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.